BRPI0821945A2 - excrescência de neurito como um ensaio para compostos de realce de memória - Google Patents
excrescência de neurito como um ensaio para compostos de realce de memóriaInfo
- Publication number
- BRPI0821945A2 BRPI0821945A2 BRPI0821945A BRPI0821945A BRPI0821945A2 BR PI0821945 A2 BRPI0821945 A2 BR PI0821945A2 BR PI0821945 A BRPI0821945 A BR PI0821945A BR PI0821945 A BRPI0821945 A BR PI0821945A BR PI0821945 A2 BRPI0821945 A2 BR PI0821945A2
- Authority
- BR
- Brazil
- Prior art keywords
- assay
- neurite outgrowth
- memory enhancement
- enhancement compounds
- compounds
- Prior art date
Links
- 238000003556 assay Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 230000006993 memory improvement Effects 0.000 title 1
- 230000014511 neuron projection development Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
- G01N2333/4706—Regulators; Modulating activity stimulating, promoting or activating activity
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1713407P | 2007-12-27 | 2007-12-27 | |
| PCT/US2008/088477 WO2009086532A1 (en) | 2007-12-27 | 2008-12-29 | Neurite outgrowth as an assay for memory enhancing compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0821945A2 true BRPI0821945A2 (pt) | 2017-05-23 |
Family
ID=40824738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0821945A BRPI0821945A2 (pt) | 2007-12-27 | 2008-12-29 | excrescência de neurito como um ensaio para compostos de realce de memória |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20100285990A1 (pt) |
| EP (1) | EP2235239A4 (pt) |
| JP (1) | JP2011511621A (pt) |
| KR (1) | KR20100106446A (pt) |
| CN (1) | CN101970729A (pt) |
| AU (1) | AU2008345015A1 (pt) |
| BR (1) | BRPI0821945A2 (pt) |
| CA (1) | CA2711031A1 (pt) |
| IL (1) | IL206525A0 (pt) |
| WO (1) | WO2009086532A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8277842B1 (en) | 2012-01-20 | 2012-10-02 | Dart Neuroscience (Cayman) Ltd. | Enteric-coated HT-2157 compositions and methods of their use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2244253C (en) * | 1996-03-15 | 2002-11-12 | Somerset Pharmaceuticals, Inc. | Method for preventing and treating peripheral neuropathy by administering selegiline |
| US20070213290A1 (en) * | 1996-10-17 | 2007-09-13 | Kingsman Alan J | Neurite regeneration |
| DK1540335T3 (da) * | 2002-08-19 | 2010-07-26 | Helicon Therapeutics Inc | Screeningsfremgangsmåder til kognitive forstækere |
-
2008
- 2008-12-29 BR BRPI0821945A patent/BRPI0821945A2/pt not_active IP Right Cessation
- 2008-12-29 JP JP2010540931A patent/JP2011511621A/ja not_active Withdrawn
- 2008-12-29 KR KR1020107014510A patent/KR20100106446A/ko not_active Withdrawn
- 2008-12-29 US US12/810,617 patent/US20100285990A1/en not_active Abandoned
- 2008-12-29 CA CA2711031A patent/CA2711031A1/en not_active Abandoned
- 2008-12-29 CN CN2008801271963A patent/CN101970729A/zh active Pending
- 2008-12-29 AU AU2008345015A patent/AU2008345015A1/en not_active Abandoned
- 2008-12-29 EP EP08868622A patent/EP2235239A4/en not_active Withdrawn
- 2008-12-29 WO PCT/US2008/088477 patent/WO2009086532A1/en not_active Ceased
-
2010
- 2010-06-21 IL IL206525A patent/IL206525A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009086532A1 (en) | 2009-07-09 |
| US20100285990A1 (en) | 2010-11-11 |
| EP2235239A1 (en) | 2010-10-06 |
| KR20100106446A (ko) | 2010-10-01 |
| CN101970729A (zh) | 2011-02-09 |
| JP2011511621A (ja) | 2011-04-14 |
| AU2008345015A1 (en) | 2009-07-09 |
| EP2235239A4 (en) | 2011-05-11 |
| CA2711031A1 (en) | 2009-07-09 |
| IL206525A0 (en) | 2010-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0812825A2 (pt) | Derivados ftalazinona como inibidores de parp-1 | |
| BRPI0913879A2 (pt) | fenilpirazinonas como inibidores de quinase | |
| BRPI0920135A2 (pt) | imidazopiridazinacarbonitrilos úteis como inibidores de quinase | |
| BRPI0811065A2 (pt) | Indazóis 5-heteroaril substituídos como inibidores de quinase | |
| BRPI0813499A2 (pt) | Compostos úteis como inibidores da quinase raf | |
| BRPI0906973A2 (pt) | Compostos e composições como inibidores de cinase. | |
| BRPI0911542A2 (pt) | compostos de quinuclina como ligantes de receptor de receptor de acetilcolina alfa-7-nicotínica | |
| BRPI0815042A2 (pt) | Compostos de pirazol | |
| BRPI0920239A2 (pt) | compostos heterocíclicos como inibidores de proteínas quinases | |
| BRPI0912475A2 (pt) | compostos como inibidores de quinase | |
| EP2210880A4 (en) | benzoxazinone- | |
| BRPI0922351A2 (pt) | compostos orgânicos | |
| BRPI0922808A2 (pt) | compostos orgânicos | |
| BRPI0922131A2 (pt) | Compostos orgânicos | |
| BRPI0922348A2 (pt) | Compostos orgânicos | |
| BRPI0922809A2 (pt) | compostos orgânicos | |
| BRPI0913966A2 (pt) | compostos orgânicos | |
| BRPI0914698A2 (pt) | compostos orgânicos | |
| BRPI0915018A2 (pt) | compostos orgânicos | |
| DK2310359T3 (da) | Organiske forbindelser | |
| BRPI0914869A2 (pt) | composição para lavagem de roupas | |
| BRPI0810462A2 (pt) | Derivados de quinolina-carboxamida como antagonistas de p2y12 | |
| BRPI0921826A2 (pt) | compostos orgânicos | |
| BRPI0907611A2 (pt) | Compostos orgânicos | |
| BRPI0918064A2 (pt) | distribuidor de substância |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |